The FDA approved the first fecal transplant therapy, Rebyota, for people with ongoing Clostridioides difficile, ABC News reported Nov. 30.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st fecal transplant therapy for C. diff
